Development and validation of a quality of life measurement for chronic skin disorders in French: VQ-Dermato

Dermatology

Volumn 199, Issue 3, 1999, Pages 213-222

  Grob, Jean Jacques ^a,b   Auquier, P ^a   Martin, S ^a   Lancon C ^a   Bonerandi, J J ^a   Bastuji, S ^c   Bernard, P ^c   Chosidow, O ^c   Guillaume, J C ^c   Roujeau, J C ^c   Sassolas, B ^c   Vaillant, L ^c  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c NONE

Author keywords

Eczema; Handicap; Leg ulcer; Psoriasis; Psychology; Quality of life; Skin disorders

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; EMOTIONAL STABILITY; FEMALE; HOSPITAL; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PAIN; PHYSICAL CAPACITY; PRIORITY JOURNAL; PRIVATE PRACTICE; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; SKIN DISEASE; SOCIAL INTERACTION; STATISTICAL ANALYSIS;

EID: 20244382074     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018250     Document Type: Article

References (15)

1. Johnston ML, Roberts J: Prevalence morbidity and cost of dermatological diseases. J Invest Dermatol 1979;73:395-401.
2. Ware JE, Sherboume CD: The MOS 36-item short-form Health Survey (SF36). Med J Care 1992;30:437-483.
3. Hunt SM, McEvent, McKenna SP: Measuring Health Status. London, Croom Helm 1986.
4. Finlay AY: Quality of life measurement in dermatology: A practical guide. Br J Dermatol 1997;136:305-314.
5. Finlay AY, Coles EC: The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-244.
6. Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, Cork MJ, Bleehen SS, Salek MS, Alien BR, Smith S, Graham-Brown RA: Cyclosporine in severe childhood atopic dermatitis: A multicenter study. J Am Acad Dermatol 1996:34:1016-1021.
7. Motley RJ, Finlay AY: How much disability is caused by acne? Clin Exp Dermatol 1989;16: 371-373.
8. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216.
9. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ: Skindex, a qualily-of-life measure for patients with skin disease: Reliability, validity and responsiveness. J Invest Dermatol 1996; 107:707-713.
10. Anderson RT, Rajagopalan R: Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997; 37:41-50.
11. Morgan M, McCreedy R, Simpson J, Hay RJ: Dermatology quality of life scales: A measure of the impact of skin diseases. Br J Dermatol 1997;136:202-206.
12. Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrica 1951;16:297-334.
13. Chren MM, Lasek RJ, Flocke SA, Syzanski SJ: Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997;11:1433-1440.
14. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Covinsky KE: Convergent and discriminant validity of a generic and a disease specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997;108: 103-107.
15. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM: Who should measure quality of life, the doctor or the patient? Br. J Cancer 1988;57:109-112.